NEW YORK ─ Mobidiag said Wednesday it has received Emergency Use Authorization in Finland for its Novodiag COVID-19 diagnostic test for the rapid and fully automated detection of the SARS-CoV-2 virus.
The Espoo, Finland-based firm said it is also seeking Emergency Use Authorization for the test in Sweden, the United Kingdom, and France.
The Novodiag COVID-19 real-time PCR assay enables on-demand detection of early COVID-19 infections in about one hour, allowing for rapid isolation and treatment guidance, Mobidiag said.